Where did our name come from?

We’re called Q’Apel for the Qu’Appelle River, a waterway that winds through Saskatchewan, Canada. Why? Because this pristine river charts a winding path, full of twists, turns, and straightaways alike. That’s what we do, too. Our cutting-edge products—neurological catheters, specifically—are designed to navigate the twists and turns of the brain’s neurovasculature, empowering therapeutic thrombectomy and cerebral aneurysm devices to deliver life-changing outcomes.

Who We Are
View All Resources

Science behind Balloon Guide Catheters in Mechanical Thrombectomy webinar.

May 21, 2020

Videos are provided for educational purposes only. It is the responsibility of the healthcare provider to determine the best course of treatment for each clinical situation.

The content and case study data are provided by physician faculty. Please consult the Walrus Balloon Guide Catheter System Instructions for Use for a complete description of Indications for Use, Warnings, Precautions, and Potential Adverse Events. At the time of this webinar, the Walrus BGC is only cleared for use in the United States.

The presenting faculty has been compensated for their services to assist in preparation and presentation of the webinar content.

play button

Related readings.

Our utmost commitment: creating what works based specifically and urgently on what’s needed. Explore additional resources, publications, and webinars to learn more.

July 8, 2025

Q’Apel Medical Announces U.S. FDA Clearance for the Zebra Neurovascular Access System and Prepares for Full U.S. Launch

July 1, 2025

Q’Apel Medical Appoints 
Stewart Strong as President and 
Chief Executive Officer

April 18, 2025

FDA Classifies Q’Apel Medical Inc.’s Worldwide Medical Device Recall and Discontinuation of its 072 Aspiration System (Hippo) as Class I

January 13, 2025

Q’Apel Medical Announces CE Mark Approval for Armadillo SelectFlex™ Neurovascular Access System